<p>The present invention relates to the identification of molecules, which are specific to CD80 and CD86 antigens. Also preferably, such antibodies are capable of inhibiting the binding of CD28 and CTLA-4 to those receptors. Those molecules are able to inhibit T cell mediated immune reactions.</p>
申请公布号
WO2004076488(A1)
申请公布日期
2004.09.10
申请号
WO2004EP01916
申请日期
2004.02.26
申请人
THERAVISION GMBH;SHERIFF, AHMED;VOGT, BIRGIT;BHARDWAJ, RANJIT, S.
